Lights... Cameras... Action

Detecting intracellular activity is easier than ever, thanks to the HitKit series from Cellomics Inc. of Pittsburgh, Pa. Relying upon dyes and fluorophores visualized by fluorescence microscopy, the HitKit series of assay reagents permits visualization of various cellular events in intact cells. The kits are comprised of buffers, fluorescent probes, and sometimes positive or negative control compounds and are optimized to increase sensitivity, specificity, and signal-to-noise ratio. This optim

Written byKelly Karpa
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The kits are comprised of buffers, fluorescent probes, and sometimes positive or negative control compounds and are optimized to increase sensitivity, specificity, and signal-to-noise ratio. This optimization, combined with each fluorophore's ability to absorb and emit light at distinct wavelengths, enables researchers to carry out multiplex assays. As such, the HitKit series of reagents is amenable to cell-based, high-content screening applications.

Four broad categories of cellular actions can be studied with the kits: indices of cell signaling, cell mitosis, cell motility and morphology, and cellular toxicity. A variety of kits are available for studying basic cell signaling properties involving transcription factor or kinase activation: NF-*B, STAT1, STAT2, STAT3, STAT5, c-Jun, ERK MAPK, p38 MAPK, and ATF-2. These transcription factors and kinases are primarily cytoplasmic until activated, when they translocate to the nucleus. Nuclear accumulation of these proteins may be observed using the kits. Analysis of compounds that induce or inhibit ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies